Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Flicker, K; Ulz, P; Höger, H; Zeitlhofer, P; Haas, OA; Behmel, A; Buchinger, W; Scheuba, C; Niederle, B; Pfragner, R; Speicher, MR.
High-resolution analysis of alterations in medullary thyroid carcinoma genomes.
Int J Cancer. 2012; 131(2):E66-E73
Doi: 10.1002/ijc.26494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Flicker Karin
- Speicher Michael
- Co-Autor*innen der Med Uni Graz
- Pfragner Roswitha
- Ulz Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hereditary and sporadic medullary thyroid carcinoma (MTC) are closely associated with RET proto-oncogene mutations. However, the role of additional changes in the tumor genomes remains unclear. Our objective was the identification of chromosomal regions involved in MTC tumorigenesis and to assess their significance by using MTC-derived cell lines. We used array-CGH (comparative genomic hybridization) to map chromosomal imbalances in 52 primary tumors and ten metastases. Eleven tumors (11/52, 21%) were hereditary and 41 (41/52, 79%) were sporadic. Among the latter, 15 tumors (15/41, 37%) harbored RET mutations. Furthermore, we characterized five MTC cell lines in detail and evaluated the tumorigenicity by severe combined immunodeficiency (SCID)-mouse experiments. Most MTCs had only few copy number changes, and losses of chromosomes 1p, 4q, 19p and 22q were observed most frequently. The number of chromosomal aberrations increased in metastases. Twenty-three percent (12/52) of the primary tumors did not even show any chromosomal gains and losses. We injected three cell lines (two of these were without chromosomal changes and pathogenic RET mutations) into immune deficient SCID mice, and in each case, we observed rapid tumor growth at the injection sites. Our data suggest that MTCs--in contrast to most other tumor entities--do not acquire a multitude of genomic imbalances. SCID mouse experiments performed with chromosomally normal cell lines and without RET mutations suggest that presently unknown submicroscopic genomic changes are sufficient in MTC tumorigenesis.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Carcinoma, Medullary - genetics Carcinoma, Medullary - pathology
- Cell Line, Tumor -
- Chromosome Aberrations -
- Chromosome Mapping -
- Comparative Genomic Hybridization -
- Female -
- Humans -
- Mice -
- Mice, SCID -
- Neoplasm Transplantation -
- Proto-Oncogene Proteins c-ret - genetics Proto-Oncogene Proteins c-ret - metabolism
- Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology
- Transplantation, Heterologous -
- Find related publications in this database (Keywords)
- medullary thyroid carcinoma
- genomic imbalances
- chromosomal instability
- RET-gene
- array-CGH